Good morning, everyone, and nice to see you again. We hope the weekend was refreshing. Now, of course, the routine of meetings and deadlines returns. And there are plenty this week. We know you can relate. So please join us as we reach for that mandatory cup of stimulation and peruse the news of the world. Have a great day and catch you later...
Bristol & AstraZeneca Diabetes Med Shows Cancer Risks (Bloomberg News)
Abbott Drug Reverses Kidney Decline In Diabetics: Study (Bloomberg News)
Avandia And Actos Raise Risk Of Eye Disease (Bloomberg News)
EMA's CHMP Recommends Novartis And Boehringer Drugs (Pharma Times)
Glenmark Receives $25M Upfront Payment From Sanofi (Economic Times)
EDITOR’S NOTE: Please check this post for updates throughout the morning